Madison, WI, July 27, 2018 – Imbed Biosciences, a developer of advanced biomaterials and soft tissue repair devices, announced today that clinical results documenting the use of its flagship product, MicroLyte® Ag Matrix resorbable antimicrobial wound matrix, will be presented at the Fall Symposium on Advanced Wound Care (SAWC) in Las Vegas, NV from November…

Madison, WI, July 3, 2018 – Imbed Biosciences, a developer of advanced biomaterials and soft tissue repair devices, announced today that the company has formally received its ISO 13485:2016 certificate.  The new certificate supersedes the existing certification and confirms that the company is compliant with the newest international standard governing the quality manufacture of medical…

Madison, WI, June 5, 2018– Imbed Biosciences, a developer of advanced biomaterials for soft tissue repair and regeneration, today announced the launch of a MicroLyte® Ag Antimicrobial Matrix clinical research program which will comprise multiple sites, studies and a nationwide patient registry. The first study, underway at Mission Health System in Asheville, NC, is an…

Madison, WI, May 31, 2018 – Imbed Biosciences, a developer of advanced biomaterials and wound care devices, announced today that its flagship product, MicroLyte® Ag Matrix, is now available to physicians and other clinicians at Rush University Medical Center in Chicago, IL. MicroLyte® Ag Matrix is the first product of its kind to combine antimicrobial silver in…

Madison, WI, April 3, 2018– Today Imbed Biosciences, Inc. announced that the Japan Patent Office has granted 14 claims of the company’s Japanese Patent Application No. 2015-541849, titled “Methods and Compositions for Wound Healing.” The granted claims provide comprehensive coverage to Imbed’s nanometer-thick polymer multilayer matrix technology, which driven by its nanoscale engineering conforms intimately…

Madison, WI, April 4, 2017 – Imbed Biosciences, a developer of advanced biomaterials and wound care devices, announced today that the company will present new data and information featuring its MicroLyte™ antimicrobial and antibiofilm wound dressings at the Spring Symposium on Advanced Wound Care (SAWC) in San Diego, CA from April 5-8, 2017. The company…

Madison, WI, September 9, 2016 – Imbed Biosciences, a developer of advanced biomaterials and wound care devices, announced today that the company has received certification from British Standards Institution (BSI) Group America, Inc. that the company complies with the requirements of ISO 13485:2003 for an integrated Quality Management System across all functions of the business,…

MADISON, WI (Aug 5, 2016) – Imbed Biosciences announced today that it has received clearance from the Food and Drug Administration (FDA) to market its patented Microfilm™ wound dressing—Microlyte® Ag, for human use. The dressing is an ultrathin hydrogel sheet as thin as human hair that is able to intimately conform to the contours of…

Bremen, Germany (May 12, 2016) – Imbed Biosciences announces that its microfilm wound dressing technology has today won the annual 2016 Wound Care Innovation Award at the European Wound Management Association (EWMA) conference in Bremen, Germany. About 6,000 medical professionals attended the conference, which is the largest such annual gathering in Europe. In total, more…

For inquiry call        1-608-237-1523
info@imbedbio.com